16-90022722-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001481.3(GAS8):c.1A>T(p.Met1?) variant causes a start lost, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000495 in 1,415,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001481.3 start_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAS8 | NM_001481.3 | c.1A>T | p.Met1? | start_lost, splice_region_variant | 1/11 | ENST00000268699.9 | NP_001472.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAS8 | ENST00000268699.9 | c.1A>T | p.Met1? | start_lost, splice_region_variant | 1/11 | 1 | NM_001481.3 | ENSP00000268699 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151928Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000158 AC: 2AN: 1263394Hom.: 0 Cov.: 31 AF XY: 0.00000162 AC XY: 1AN XY: 616714
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151928Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74222
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 33 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2021 | This sequence change affects the initiator methionine of the GAS8 mRNA. The next in-frame methionine is located at codon 26. This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with GAS8-related conditions. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at